We create value for our customers and society by innovating science-based solutions that help save lives, extend lives and improve the overall quality of life.

At the same time we are committed to sustainable development in all its broad and diverse meanings. In part, this means striving to reduce our use of natural resources such as water and energy, striving to reduce our carbon footprint and to reduce the generation of waste.

In our operations, we engage and empower our employees and teams to work towards our Vision Zero – meaning zero workplace injuries, zero manufacturing process incidents, zero emissions beyond regulatory limits, and zero transportation incidents. In the workplace, we aim to protect our colleagues by identifying and eliminating potential hazards.

This commitment to sustainability is a core part of the ethical principles that drive us.

One of our long-term goals is to improve our sustainability performance and reduce our environmental footprint. To achieve these aspirations, we have set specific environmental targets based on the reported values for full year 2018, until 2030. 

2019 – 2030 targets for greenhouse gases, energy and waste: minus 4% per annum measured against total revenue. Ambition: 100% renewable electricity by 2025

The targets are intensity targets based on million CHF sales to factor in Lonza’s continued growth. They also reflect our diverse and evolving product portfolio, which includes the manufacturing of pharmaceutical ingredients, medical capsules, food supplements, gene therapy and cell media, and the licensing of technologies and systems.

In view of our long-term ambition of reaching net-zero greenhouse gas (GHG) emissions by 2050, in 2023 we have submitted a letter of commitment to the Science-Based Targets initiative (SBTi), with plans to set new targets to reduce absolute scope 1 and 2 GHG emissions by more than 40% by the end of 2030 (from a 2021 base year).